tretazicar has been researched along with Experimental Mammary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Djeha, HA; Irvine, AS; Lipinski, KS; Mountain, A; Pelech, S; Todryk, SM; Wrighton, CJ | 1 |
Donaldson, J; Morgan, JE; Talbot, K; Twentyman, PR; Workman, P; Wright, KA | 1 |
2 other study(ies) available for tretazicar and Experimental Mammary Neoplasms
Article | Year |
---|---|
Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70.
Topics: Adenoviridae; Animals; Apoptosis; Aziridines; Female; Genes, Transgenic, Suicide; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; HSP70 Heat-Shock Proteins; Interferon-gamma; Mammary Neoplasms, Experimental; Mice; Nitroreductases; Prodrugs; Proteomics; T-Lymphocytes; Transfection; Up-Regulation | 2005 |
CB 1954 revisited. II. Toxicity and antitumour activity.
Topics: Animals; Aziridines; Azirines; Colonic Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lomustine; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Experimental | 1986 |